The Tech Data

The Tech Data

ZIVO Bioscience Issues Special Letter to Shareholders

ZIVO Bioscience shifts strategy to preserve capital and unlock shareholder value amid approaching revenue inflection point ZIVO Bioscience, Inc. has issued a detailed and strategically significant letter to shareholders from its Chairman, President, and Chief Executive Officer, John B. Payne,…